On November 2, 2016, the Center for Medicare and Medicaid Services (CMS) issued the final rule
updating payment policies and payment rates for physicians under the Medicare Physician Fee Schedule (MPFS) for 2017. Within this document and addendum are updates to the relative value units (RVU), which include work RVUs, practice expense (PE) RVUs, malpractice (MP) RVUs, as well as the Medicare conversion factor.
Following is a summary of some of the changes affecting reimbursement for AANEM members for the calendar year (CY) 2017.
Work RVUs for all electrodiagnostic and neuromuscular codes monitored by AANEM remained unchanged for CY 2017. Please visit our website for more information.
Needle EMG codes performed without nerve conduction studies (95861-95868) saw small reimbursement increases due to slightly increased PE and Malpractice RVUs. Increases to RVU’s ranged from 0.29% to 2.59%.
Nerve Conduction Study codes (95907-95911, 95913) saw small reimbursement increases due to increases in PE and Malpractice RVU’s. Increases to RVU’s ranged from 0.36% to 5.63%.
Autonomic Testing and Evoked Potential Testing saw decreases due to downward adjustments of PE and MP RVU’s. Physician work RVU’s remained the same for these codes.
The conversion factor for CY 2017 has been finalized at $35.8887, which is up $0.0844 from the conversion factor of $35.8043 utilized in CY 2016.
For a complete analysis of RVU adjustments to electrodiagnostic and neuromuscular medicine specific codes in the 2017 Physician Fee Schedule as well as the effect these changes will have on reimbursement, please visit our website here.
To support AANEM’s continuing advocacy efforts, consider donating to the Advocacy Fund here